Online Program

Social Determinants and Cancer

Tuesday, November 5, 2013: 8:30 a.m. - 10:00 a.m.
Social determinants play a critically important role in the incidence, morbidity, and mortality of cancer. This session will address SES disparities in cancer treatment and survival, the efficacy of strategies to enhance smoking cessation among low-SES, predominantly racial/ethnic minority smokers, and geographic disparities in cancer morality in the United States. The content of this session will be geared toward public health and behavioral science researchers, community health educators, and individuals working to address cancer-related health disparities.
Session Objectives: Explain the role of adherence to quality indicators in reducing SES disparities in survival among non-small cell lung cancer patients. Discuss the results of a group-randomized smoking cessation trial designed to test whether public housing residents trained as Tobacco Treatment Advocates (TTAs) can increase utilization of smoking cessation resources and smoking cessation rates among smokers in public housing. Define the components of an effective cancer needs assessment. Describe geographic distribution of US mortality from malignant neoplasm of the trachea, bronchus, and lung according to race, ethnicity, and gender Describe disparities in prostate cancer treatment selection related to sociodemographic factors.
Stephanie Silvera, PhD, CPH

Effects of policy change on smoking status for Boston public housing residents   
Tegan Evans, MPH, Jessica Davine, MSW/MPH, Alan Geller, RN, MPH and Daniel Brooks, DSc, MPH
A model for cancer assessments that generate effective local action targeting cancer disparities: Role of the quality of cancer care continuum   
Carlin Rafie, Ph.D., R.D., Amy H Smith, PhD, CHES, Resa Jones, MPH, PhD, Arpita Aggarwal, M.D., Justine Young, RN, BSN, MPH, Susan Mathena, BSMT, Karen Gregory, HS-BCP, MPH, Jim Martin, Ph.D., Brian Cassel, Ph.D., Maghboeba Mosavel, Ph.D., Robert Houlihan, DHA, MBA, FACHE, Timur Korshin and Mary Helen Hackney, M.D.
Hot-spot analysis of malignant neoplasm of the trachea, bronchus and lung in the US   
Robert S. Levine, MD, Katy Kilbourne, MS, Paul Robinson, PhD, Barbara Kilbourne, PhD, Tyler Skelton, MS, Maria Mejia de Grubb, MD, MPH, Darryl Hood, PhD and Paul Juarez, PhD
Disparities in prostate cancer treatment selection in the state of Florida: The impact of socioeconomic status and education level   
Donald Parris, PhD, CCRC, Noella A. Dietz, PhD, Edward Trapido, Sc.D, F.A.C.E., David J. Lee, PhD and Tulay Koru-Sengul, MHS, PhD

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Cancer Forum
Endorsed by: Medical Care, Asian Pacific Islander Caucus for Public Health

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)

See more of: Cancer Forum